Trexquant Investment’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.83M	Sell	406,102 -136,393	-25%	-$711K	0.01%	1037
2025 Q4	$3.34M	Buy	542,495 +143,203	+36%	+$1.04M	0.03%	778
2025 Q3	$2.89M	Buy	+399,292	New	+$2.37M	0.03%	759
2025 Q2	–	Sell	-107,431	Closed	-$953K	–	1759
2025 Q1	$953K	Buy	107,431 +15,055	+16%	+$181K	0.01%	1107
2024 Q4	$1.27M	Sell	92,376 -42,569	-32%	-$785K	0.01%	1019
2024 Q3	$3.7M	Sell	134,945 -75,802	-36%	-$2.05M	0.05%	589
2024 Q2	$5.15M	Buy	+210,747	New	+$4.62M	0.08%	397
2023 Q3	–	Sell	-27,604	Closed	-$640K	–	1702
2023 Q2	$640K	Sell	27,604 -31,300	-53%	-$683K	0.02%	909
2023 Q1	$1.37M	Buy	58,904 +39,946	+211%	+$811K	0.04%	598
2022 Q4	$275K	Buy	+18,958	New	+$353K	0.01%	1132
2021 Q1	–	Sell	-12,810	Closed	-$253K	–	1346
2020 Q4	$253K	Buy	+12,810	New	+$207K	0.03%	784
2017 Q2	–	Sell	-37,654	Closed	-$723K	–	1043
2017 Q1	$723K	Buy	37,654 +9,428	+33%	+$167K	0.09%	384
2016 Q4	$471K	Buy	+28,226	New	+$511K	0.07%	465
2016 Q3	–	Sell	-51,305	Closed	-$1.57M	–	898
2016 Q2	$1.57M	Buy	51,305 +31,621	+161%	+$1.1M	0.21%	135
2016 Q1	$737K	Buy	+19,684	New	+$742K	0.09%	393